For example, the Cobas® EGFR Mutation Test v2 is used for non-small-cell lung carcinoma since EGFR, a KRAS-activating receptor, is often mutated in this particular cancer (65). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.